drugset / Trial / NCT00519246

Comparison of Pain Therapeutic Effects After Benign Mastectomy

NCT00519246

Phase 4 Completed 2000 enrolled Nanjing Medical University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

With the incremental trend of benign breast tumor, the surgical process of mastectomy was proceeded too much every day, especially in the Maternal Health Care Hospital, but whether the investigators can find another way to relieve the postoperative pain after such an operation is still unknown. The investigators hypothesized that the pain from the relatively small surgery may not be significant compared to different treatments, even if no drug was delivered to them. The investigators are enrolling patients who underwent mastectomy from benign breast tumor, and are observing the analgesic effects of different drugs.

Timeline

Start
2007-02
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Butorphanol Other / unclassified 1 mg Intravenous
Subject Butorphanol Other / unclassified 2 mg Intravenous
Subject Flurbiprofen Small molecule 50 mg Intravenous
Subject Flurbiprofen Small molecule 100 mg Intravenous
Subject Tramadol Other / unclassified 10 mg Intravenous
Subject Tramadol Other / unclassified 20 mg Intravenous

Indications